RETRACTED: Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma.

Zhu K, Sun D, Zou X, Liu R, Wang Z

DOI: 10.1016/j.intimp.2020.106474
Published: 2020 Jul
Container: International immunopharmacology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2020.106474,
  title = {RETRACTED: Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma.},
  author = {Zhu K and Sun D and Zou X and Liu R and Wang Z},
  year = {2020},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2020.106474},
  url = {https://doi.org/10.1016/j.intimp.2020.106474}
}

RIS

TY  - JOUR
TI  - RETRACTED: Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma.
AU  - Zhu K
AU  - Sun D
AU  - Zou X
AU  - Liu R
AU  - Wang Z
PY  - 2020
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2020.106474
UR  - https://doi.org/10.1016/j.intimp.2020.106474
ER  -

APA

K, Z., D, S., X, Z., R, L., & Z, W. (2020). RETRACTED: Interleukin-36 receptor antagonist is associated with the progression of renal cell carcinoma.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2020.106474

Source records

pubmed · retrieved 2026-09-25T09:05:13.911Z